COMP <GO>
SIGA vs LLY // 10Y YIELD & FRED MACRO BETA
SIGA Technologies Inc. (NASDAQ) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: SIGA 4
— LLY 9
■ METRIC PARITY
LAST: $3.04 (-4.40%) • MKT CAP: $228.5M
macro-sensitivity
—
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.29T
macro-sensitivity
0.51
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (SIGA VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | SIGA | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 68.60% | 83.64% | -15.04 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 42.70% | 32.36% | +10.34 | SIGA | /roic <GO> |
| EV/EBITDA & P/E Valuation | 4.8x | 36.4x | -31.62 | SIGA | /valuation <GO> |
| Free Cash Flow Yield | 19.03% | 2.30% | +16.73 | SIGA | /fcf-yield <GO> |
| Operating Margin | 25.10% | 40.21% | -15.11 | LLY | /operating-margins <GO> |
| Net Profit Margin | 24.60% | 31.90% | -7.30 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | -31.80% | 45.51% | -77.31 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.49% | -0.49 | LLY | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 8.22 | 9.29 | -1.07 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 6/9 | 9/9 | -3.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | 6.77% | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 36.7 | 66.6 | -29.91 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta ACTIVE | — | 0.51 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 9.1x | 30.6x | -21.52 | SIGA | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $228.5M | $1.29T | -$1.29T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | SIGA REV | LLY REV | SIGA GROSS % | LLY GROSS % | SIGA FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $94.6M | $65.18B | 68.6% | 83.0% | $43.5M | $16.81B |
| FY 2024 | $138.7M | $45.04B | 77.4% | 81.3% | $48.8M | $8.82B |
| FY 2023 | $139.9M | $34.12B | — | 79.3% | $94.8M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
SIGA // BETA —
LLY // BETA 0.51